Accession Number : ADB162349
Title : Conduct Studies to Synthesize Antiviral Compounds.
Descriptive Note : Final rept. 20 Sep 90-19 Sep 91,
Corporate Author : ANDRULIS RESEARCH CORP BETHESDA MD
Personal Author(s) : Gill, Devinder
Report Date : 18 FEB 1992
Pagination or Media Count : 24
Abstract : Ribavirin a broad spectrum antiviral compound shows promise in vitro and in vivo against many viral diseases. The specific aim of this project was to synthesize a polymeric drug conjugate of ribavirin to provide time-release doses with enhanced endocytosis. A practical and standard approach was planned to couple ribavirin with carboxy-dextran (MW 46,000) by protecting 2', 3'-hydroxyl groups of ribavirin and then coupling ribavirin with polymer via an ester linkage to the 5'-hydroxyl group. This report describes successful synthesis and characterization of 2' 3'-isopropylidine ribavirin and carboxy-dextran. Conjugation of ribavirin to polymer may provide enhanced solubility and sustained release of drug. Further, a recommendation is also made in this report to achieve successful synthesis of conjugates.
Descriptors : , ANTIVIRAL AGENTS, DRUGS, ESTERS, IN VITRO ANALYSIS, IN VIVO ANALYSIS, LINKAGES, POLYMERS, RELEASE, SOLUBILITY, SYNTHESIS, VIRUS DISEASES.
Subject Categories : Pharmacology
Distribution Statement : APPROVED FOR PUBLIC RELEASE